Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 67.91M | $ 35.34M | 52.03% |
3/31/2025 | $ 69.94M | $ 34.65M | 49.54% |
12/31/2024 | $ 75.58M | $ 31.28M | 41.39% |
9/30/2024 | $ 76.75M | $ 30.65M | 39.93% |
6/30/2024 | $ 78.52M | $ 31.2M | 39.74% |
3/31/2024 | $ 81.51M | $ 32.43M | 39.79% |
12/31/2023 | $ 81.78M | $ 33.49M | 40.95% |
9/30/2023 | $ 87.75M | $ 32.14M | 36.62% |
6/30/2023 | $ 89.38M | $ 33M | 36.93% |
3/31/2023 | $ 89.47M | $ 31.9M | 35.66% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: GP [ $ 31.65M ] / Assets [ $ 96.01M ]
(=) GPA [ 32.97% ]
Minimum
Mar 31, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |